Bedford, MA, United States
Bedford, MA, United States

Time filter

Source Type

Patent
Counterpoint Health Solutions | Date: 2014-07-01

A method comprising analyzing multiple component data between or among categories of individuals to develop therapeutic lead compounds through analysis of biochemical networks linking the genome, transcriptome, proteome, metabolome, gut microbiome and environmental factors.


Patent
Counterpoint Health Solutions | Date: 2013-03-14

Indole-3-propionic acid as a marker and for treatment for Huntington Disease.


Patent
Counterpoint Health Solutions | Date: 2014-10-15

Indole-3-propionic acid as a marker and for treatment for Huntington Disease.


Patent
Counterpoint Health Solutions | Date: 2013-11-27

Indole-3-propionic acid as a marker and for treatment for Huntington Disease.


Patent
Counterpoint Health Solutions | Date: 2015-08-17

A method comprising analyzing multiple component data between or among categories of individuals to develop therapeutic lead compounds through analysis of biochemical networks linking the genome, transcriptome, proteome, metabolome, gut microbiome and environmental factors.


Patent
Counterpoint Health Solutions | Date: 2015-08-17

A method comprising analyzing multiple component data between or among categories of individuals to develop therapeutic lead compounds through analysis of biochemical networks linking the genome, transcriptome, proteome, metabolome, gut microbiome and environmental factors.


Patent
Counterpoint Health Solutions | Date: 2015-06-11

A method for treatment of virus-based diseases of the skin, in particular, herpes simplex virus type-1 and herpes zoster, which comprises topically administering to the skin of a subject suffering from a virus-based disease of the skin a therapeutically amount of an aqueous, aqueous/alcohol, or natural plant oil extract of dandelion.


Patent
Counterpoint Health Solutions | Date: 2015-01-30

A method for determining the systems biology state of an animal, which comprises determining levels of small molecules covalently bound to macromolecules (CBSM) in samples from that animal, and using said levels to determine the risk, diagnostic state and progression of disease in that animal. A therapy development method for determining the structure of covalently bound molecules and their precursors and modifying the sources and mechanisms causing such binding to reduce disease risk and progression.


Patent
Counterpoint Health Solutions | Date: 2015-04-16

Indole-3-propionic acid as a marker and for treatment for Huntington Disease.


Loading Counterpoint Health Solutions collaborators
Loading Counterpoint Health Solutions collaborators